Molecular underpinnings of Th17 immune-regulation and their implications in autoimmune diabetes

Cytokine

Volumn 71, Issue 2, 2015, Pages 366-376

  Kumar, Prabhakaran ^a   Subramaniyam, Ganesan ^b  

^a BHARATHIDASAN UNIVERSITY   (India)

^b Madurai Meenakshi College   (India)

Author keywords

Autoimmune diabetes; IL 17; ROR t; T helper cell plasticity; Th17 cells

Indexed keywords

HYDROXYCHLOROQUINE; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 21; INTERLEUKIN 23; INTERLEUKIN 6; MYELOID DIFFERENTIATION FACTOR 88; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 3; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; MICRORNA;

ADAPTIVE IMMUNITY; AUTOIMMUNE DISEASE; CELL LINEAGE; CELL TRANSPORT; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; DIABETES MELLITUS; GENE EXPRESSION PROFILING; GOBLET CELL; HUMAN; IMMUNOMODULATION; IMMUNOPATHOGENESIS; IMMUNOREGULATION; INFLAMMATORY BOWEL DISEASE; LYMPHOCYTE DIFFERENTIATION; MEMBRANE PERMEABILITY; MOLECULAR DYNAMICS; NONHUMAN; PLASTICITY; PROTEIN BINDING; REGULATORY T LYMPHOCYTE; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; TH17 CELL; ANIMAL; AUTOIMMUNITY; CELL DIFFERENTIATION; CYTOLOGY; DISEASE MODEL; DNA METHYLATION; GENETIC EPIGENESIS; GENETIC TRANSCRIPTION; IMMUNOLOGY; INSULIN DEPENDENT DIABETES MELLITUS; METABOLISM; MOUSE; PROTEIN SYNTHESIS; RNA PROCESSING; TH1 CELL;

MUS;

ANIMALS; AUTOIMMUNITY; CELL DIFFERENTIATION; CELL LINEAGE; DIABETES MELLITUS, TYPE 1; DISEASE MODELS, ANIMAL; DNA METHYLATION; EPIGENESIS, GENETIC; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; MICE; MICRORNAS; PROTEIN BIOSYNTHESIS; RNA PROCESSING, POST-TRANSCRIPTIONAL; TH1 CELLS; TH17 CELLS; TRANSCRIPTION, GENETIC;

EID: 84921264758     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2014.10.010     Document Type: Review

References (142)

1. Karin M., Lawrence T., Nizet V. Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer. Cell 2006, 124:823-835.
2. Nathan C. Points of control in inflammation. Nature 2002, 420:846-852.
3. Springer T.A. Traffic signals for lymphocyte recirculation and leukocyte migration: the multistep paradigm. Cell 1994, 76:301-314.
4. Zhu J., Paul W.E. CD4 T cells: fates, functions, and faults. Blood 2008, 112(5):1557-1569.
5. Bevan M.J. Helping the CD8 (+) T-cell response. Nat Rev Immunol 2004, 4(8):595-602.
6. + T cells in immunity to viruses. Nat Rev Immunol 2012, 12(2):136-148.
7. Muranski P., Restifo N.P. Adaptive immunotherapy of cancer using CD4(+) T cells. Curr Opin Immunol 2009, 21(2):200-208.
8. Mosmann T.R., Coffman R.L. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989, 7:145-173.
9. Romagnani S. The Th1/Th2 paradigm. Immunol Today 1997, 18(6):263-266.
10. Afkarian M., Sedy J.R., Yang J., Jacobson N.G., Cereb N., Yang S.Y., et al. T-bet is a STAT1-induced regulator of IL-12R expression in naive CD4(+) T cells. Nat Immunol 2002, 3(6):549-557.
11. Szabo S.J., Kim S.T., Costa G.L., Zhang X., Fathman C.G., Glimcher L.H. A novel transcription factor, Tbet, directs Th1 lineage commitment. Cell 2000, 100(6):655-669.
12. Oestreich K.J., Weinmann A.S. Transcriptional mechanisms that regulate T helper 1 cell differentiation. Curr Opin Immunol 2012, 24(2):191-195.
13. Kaplan M.H., Schindler U., Smiley S.T., Grusby M.J. Stat6 is required for mediating responses to IL-4 and for the development of Th2 cells. Immunity 1996, 4(3):313-319.
14. Zheng W.P., Flavell R.A. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 1997, 89(4):587-596.
15. Szabo S.J., Jacobson N.G., Dighe A.S., Gubler U., Murphy K.M. Developmental commitment to the Th2 lineage by extinction of IL-12 signaling. Immunity 1995, 2(6):665-675.
16. Ouyang W., Ranganath S.H., Weindel K., Bhattacharya D., Murphy T.L., Sha W.C., et al. Inhibition of Th1 development mediated by GATA-3 through an IL-4-independent mechanism. Immunity 1998, 9(5):745-755.
17. Usui T., Preiss J.C., Kanno Y., Yao Z.J., Bream J.H., O'Shea J.J., et al. T-bet regulates Th1 responses through essential effects on GATA-3 function rather than on IFNG gene acetylation and transcription. J Exp Med 2006, 203(3):755-766.
18. + effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 2005, 6(11):1123-1132.
19. Park H., Li Z., Yang X.O., Chang S.H., Nurieva R., Wang Y.H., et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 2005, 6(11):1133-1141.
20. Laurence A., Tato C.M., Davidson T.S., Kanno Y., Chen Z., Yao Z., et al. Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity 2007, 26:371-381.
21. Wing K., Fehervari Z., Sakaguchi S. Emerging possibilities in the development and function of regulatory T cells. Int Immunol 2006, 18:991-1000.
22. Williams L.M., Rudensky A.Y. Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3. Nat Immunol 2007, 8:277-284.
23. + regulatory T cells. J Exp Med 2005, 201:1061-1067.
24. Shull M.M., Ormsby I., Kier A.B., Pawlowski S., Diebold R.J., Yin M., et al. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 1992, 359:693-699.
25. Maddur M.S., Miossec P., Kaveri S.V., Bayry J. Th17 cells: biology, pathogenesis of autoimmune and inflammatory diseases and therapeutic strategies. Am J Pathol 2012, 181(1):8-19.
26. Ivanov I.I., McKenzie B.S., Zhou L., Tadokoro C.E., Lepelley A., Lafaille J.J., et al. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 2006, 126(6):1121-1133.
27. Yang X.O., Pappu B.P., Nurieva R., Akimzhanov A., Kang H.S., Chung Y., et al. T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR[alpha] and ROR. Immunity 2008, 28:29-39.
28. Oppmann B., Lesley R., Blom B., Timans J.C., Xu Y., Hunte B., et al. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 2000, 13(5):715-725.
29. Bettelli E., Carrier Y., Gao W., Korn T., Strom T.B., Oukka M., et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006, 441:235-238.
30. Mangan P.R., Harrington L.E., O'Quinn D.B., Helms W.S., Bullard D.C., Elson C.O., et al. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 2006, 441:231-234.
31. Veldhoen M., Hocking R.J., Atkins C.J., Locksley R.M., Stockinger B. TGF-beta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 2006, 24:179-189.
32. Korn T., Bettelli E., Gao W., Awasthi A., Jager A., Strom T.B., et al. IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature 2007, 448:484-487.
33. Nurieva R., Yang X.O., Martinez G., Zhang Y., Panopoulos A.D., Ma L., et al. Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature 2007, 448:480-483.
34. Zhou L., Ivanov I.I., Spolski R., Min R., Shenderov K., Egawa T., et al. IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat Immunol 2007, 8:967-974.
35. Zhou L., Lopes J.E., Chong M.M., Ivanov I.I., Min R., Victora G.D., et al. TGF-beta-induced Foxp3 inhibits TH17 cell differentiation by antagonizing RORgammat function. Nature 2008, 453:236-240.
36. Batten M., Li J., Yi S., Kljavin N.M., Danilenko D.M., Lucas S., et al. Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells. Nat Immunol 2006, 7:929-936.
37. Gorham J.D., Guler M.L., Fenoglio D., Gubler U., Murphy K.M. Low dose TGF-beta attenuates IL-12 responsiveness in murine Th cells. J Immunol 1998, 161:1664-1670.
38. Gorelik L., Fields P.E., Flavell R.A. Cutting edge: TGF-beta inhibits Th type 2 development through inhibition of GATA-3 expression. J Immunol 2000, 165:4773-4777.
39. + T cells at priming and at recall: differential involvement of Stat4 and T-bet. J Immunol 2005, 174:5950-5958.
40. Ghoreschi K.l., Laurence A., Yang X.P., Tato C.M., McGeachy M.J., Konkel J.E., et al. Generation of pathogenic T(H)17 cells in the absence of TGF-beta signalling. Nature 2010, 467(7318):967-971.
41. Gulen M.F., Kang Z., Bulek K., Youzhong W., Kim T.W., Chen Y., et al. The receptor SIGIRR suppresses Th17 cell proliferation via inhibition of the interleukin-1 receptor pathway and mTOR kinase activation. Immunity 2010, 32(1):54-66.
42. Chung Y., Chang S.H., Martinez G.J., Yang X.O., Nurieva R., Kang H.S., et al. Critical regulation of early Th17 cell differentiation by interleukin-1 signaling. Immunity 2009, 30(4):576-587.
43. Chen Q., Yang W., Gupta S., Biswas P., Smith P., Bhagat G., et al. IRF-4-binding protein inhibits interleukin-17 and interleukin-21 production by controlling the activity of IRF-4 transcription factor. Immunity 2008, 29(6):899-911.
44. Veldhoen M., Hirota K., Westendorf A.M., Buer J., Dumoutier L., Renauld J.C., et al. The aryl hydrocarbon receptor links T(H)17-cell mediated autoimmunity to environmental toxins. Nature 2008, 453(7191):106-116.
45. Ivanov I.I., Frutos L., Manel N., Yoshinaga K., Rifkin D.B., Sartor R.B., et al. Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. Cell Host Microbe 2008, 4:337-349.
46. Garrett W.S., Gallini C.A., Yatsunenko T., Michaud M., DuBois A., Delaney M.L., et al. Enterobacteriaceae act in concert with the gut microbiota to induce spontaneous and maternally transmitted colitis. Cell Host Microbe 2010, 8:292-300.
47. Wu H.J., Ivanov I.I., Darce J., Hattori K., Shima T., Umesaki Y., et al. Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells. Immunity 2010, 32:815-827.
48. Lee Y.K., Menezes J.S., Umesaki Y., Mazmanian S.K. Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis. Proc Natl Acad Sci USA 2011, 108:4615-4622.
49. Kriegel M.A., Sefik E., Hill J.A., Wu H.J., Benoist C., Mathis D. Naturally transmitted segmented filamentous bacteria segregate with diabetes protection in nonobese diabetic mice. Proc Natl Acad Sci USA 2011, 108:11548-11553.
50. Khader S.A., Gaffen S.L., Kolls J.K. Th17 cells at the crossroads of innate and adaptive immunity against infectious diseases at the mucosa. Mucosal Immunol 2009, 2:403-411.
51. Happel K.I., Zheng M., Young E., Quinton L.J., Lockhart E., Ramsay A.J., et al. Cutting edge: roles of Toll like receptor 4 and IL-23 in IL-17 expression in response to Klebsiella pnemoniae infection. J Immunol 2003, 170:4432-4436.
52. Davila E., Kolls J. A "Toll" for Th17 cell expansion. J Leukoc Biol 2010, 88:5-7.
53. Akira S., Hemmi H. Recognition of pathogen-associated molecular patterns by TLR family. Immunol Lett 2003, 85:85-95.
54. Lyakh L., Trinchieri G., Provezza L., Carra G., Gerosa F. Regulation of interleukin-12/interleukin-23 production and the T-helper 17 response in humans. Immunol Rev 2008, 226:112-131.
55. Kerrigan A.M., Brown G.D. Syk-coupled C-type lectins in immunity. Trends Immunol 2011, 32:151-156.
56. LeibundGut-Landmann S., Gross O., Robinson M.J., Osorio F., Slack E.C., Tsoni S.V., et al. Syk- and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17. Nat Immunol 2007, 8:630-638.
57. Schoenen H., Bodendorfer B., Hitchens K., Manzanero S., Werninghaus K., Nimmerjahn F., et al. Cutting edge: Mincle is essential for recognition and adjuvanticity of the mycobacterial cord factor and its synthetic analog trehalose-dibehenate. J Immunol 2010, 184:2756-2760.
58. Dennehy K.M., Willment J.A., Williams D.L., Brown G.D. Reciprocal regulation of IL-23 and IL-12 following co-activation of Dectin-1 and TLR signaling pathways. Eur J Immunol 2009, 39:1379-1386.
59. Wei B., Pei G. MicroRNAs: critical regulators in Th17 cells and players in disease. Cell Mol Immunol 2010, 7:175-181.
60. Du C., Liu C., Kang J., Zhao G., Ye Z., Huang S., et al. Micro RNA miR-326 regulates Th17 differentiation and is associated with the pathogenesis of multiple sclerosis patients. Nat Immunol 2009, 10:1252-1259.
61. Moison J., Grenningloh R., Bettelli E., Oukka M., Ho I.C. Ets-1 is a negative regulator of Th17 differentiation. J Exp Med 2007, 204:2825-2835.
62. Mycko M.P., Cichalewska M., Machlanska A., Cwiklinska H., Mariasiewicz M., Selmaj K.W. MicroRNA-301a regulation of a T-helper 17 immune response controls autoimmune demyelination. Proc Natl Acad Sci USA 2012, 109(20):E1248-E1257.
63. Krebs C.F., Kapffer S., Paust H.J., Schmidt T., Bennstein S.B., Peters A., et al. MicroRNA-155 drives TH17 immune response and tissue injury in experimental crescentic GN. J Am Soc Nephrol 2013, 24(12):1955-1965.
64. Othy S., Hegde P., Topcu S., Sharma M., Maddur M.S., Lacroix-Desmazes S., et al. Intravenous gammablobulin inhibits encephalitogenic potential of pathogenic T cells and interferes with their trafficking to the central nervous system implicating sphingosine-1 phosphate receptor 1-mammalian target of rapamycin axis. J Immunol 2013, 190.
65. Cua D.J., Sherlock J., Chen Y., et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 2003, 421:744-748.
66. Komiyama Y., Nakae S., Matsuki T., Nambu A., Ishigame H., Kakuta S., et al. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J Immunol 2006, 177:566-573.
67. Bruckener K.E., el Baya A., Galla H.J., Schmidt M.A. Permeabilization in a cerebral endothelial barrier model by pertussis toxin involves the PKC effector pathway and is abolished by elevated levels of cAMP. J Cell Sci 2003, 116:1837-1846.
68. Kerfoot S.M., Long E.M., Hickey M.J., Andonegui G., Lapointe B.M., et al. TLR4 contributes to disease-inducing mechanisms resulting in central nervous system autoimmune disease. J Immunol 2004, 173:7070-7077.
69. Racke M.K., Hu W., Lovett-Racke A.E. PTX cruiser: driving autoimmunity via TLR4. Trends Immunol 2005, 26:289-291.
70. Warfel J.M., Merkel T.J. Bordetella pertussis infection induces a mucosal IL-17 response and long-lived Th17 and Th1immune memory cells in nonhuman primates. Mucosal Immunol 2013, 6:787-796.
71. Spensieri F., Fedele G., Fazio C., Nasso M., Stefanelli P., Mastrantonio P., et al. Bordetella pertussis inhibition of interleukin-12 (IL-12) p70 in human monocyte-derived dendritic cells blocks IL-12 p35 through adenylate cyclase toxin-dependent cyclic AMP induction. Infect Immun 2006, 74:2831-2838.
72. Shen H., Gooall J.C., Hill Gaston J.S. Frequency and phenotype of peripheral blood Th17 cells in ankylosing spondylitis and rheumatoid arthritis. Arthritis Rheum 2009, 60:1647-1656.
73. Kotake S., Udagawa N., Takahashi N., et al. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis". J Clin Invest 1999, 103:1345-1352.
74. Attur M.G., Patel R.N., Abramson S.B., Amin A.R. Interleukin-17 up-regulation of nitric oxide production in human osteoarthritis cartilage. Arthritis Rheum 1997, 40:1050-1053.
75. Lubberts E., Koenders M.I., Van den Berg W.B. The role of T-cell interleukin-17 in conducting destructive arthritis: lessons from animal models. Arthiritis Res Ther 2005, 7:29-37.
76. Wong C.K., Lit L.C.W., Tam L.S., Li E.K.M., Wong P.T.Y., Lam C.W.K. Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: implications for Th17-mediated inflammation in auto-immunity. Clin Immunol 2008, 127:385-393.
77. Yang J., Chu Y., Yang X., Gao D., Zhu L., Wan L., et al. Th17 and nTeg cell population dynamics in systemic lupus erythmatosus. Arthritis Rheum 2009, 60:1472-1483.
78. Sawalha A.H., Kaufman K.M., Kelly J.A., Adler A.J., Aberie T., Kilpatrick J., et al. Genetic association of IL-21 polymorphisms with systemic lupus erythmatosus. Ann Rheum Dis 2008, 67:458-461.
79. Webb R., Merril J., Kelly J.A., Sestak A., kaufman K.M., Langefeld C.D., et al. A polymorphism with IL-21R confers risk for systemic lupus erythmatosus. Arthritis Rheum 2009, 60:2402-2407.
80. Silva J.C.D., Mariz H.A., Rocha L.F.D., et al. Hydroxychloroquine decreases Th17-related cytokines in systemic lupus erythematosus and rheumatoid arthritis patients. Clinics 2013, 68:766-771.
81. Zenewicz L.A., Antov A., Flavell R.A. CD4 T-cell differentiation and inflammatory bowel disease. Trends Mol Med 2009, 15:199-207.
82. Duerr R.H., Taylor K.D., Brant S.R., et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 2006, 314:1461-1463.
83. Fujino S., Andoh A., Bamba S., et al. Increased expression of interleukin 17 in inflammatory bowel disease. Gut 2003, 2003(52):65-70.
84. Zenewicz L.A., Yancopoulos G.D., Valenzuela D.M., Murphy A.J., Stevens S., Flavell R.A. Innate and adaptive Il-22 protects mice from inflammatory bowel disease. Immunity 2008, 29:947-957.
85. Esplugues E., Huber S., Gagliani N., Hauser A.E., Town T., Wan Y.Y., et al. Control of TH17 cells occurs in the small intestine. Nature 2011, 475:514-518.
86. McGeachy M.J., Chen Y., Tato C.M., Laurence A., Joyce-Shaikh B., Blumenschein W.M., et al. The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17-producing effector T helper cells in vivo. Nat Immunol 2009, 10(3):314-324.
87. McGeachy M.J., Bak-Jensen K.S., Chen Y., Tato C.M., Blumenschein W., McClanahan T., et al. TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain TH-17 cell-mediated pathology. Nat Immunol 2007, 8(12):1390-1397.
88. Lee Y.K., Turner H., Maynard C.L., Oliver J.R., Chen D., Elson C.O., et al. Late developmental plasticity in the T helper 17 lineage. Immunity 2009, 30:92-107.
89. Hymowitz S.G., Filvaroff E.H., Yin J.P., Lee J., Cai L., Risser P., et al. IL-17s adopt a cystine knot fold: structure and activity of a novel cytokine, IL-17F, and implications for receptor binding. EMBO J 2001, 20:5332-5341.
90. Lee Y., Awasthi A., Yosef N., Quintana F.J., Xiao S., Peters A., et al. Induction and molecular signature of pathogenic TH17 cells. Nat Immunol 2012, 13:991-999.
91. Fleetwood A.J., Cook A.D., Hamilton J.A. Functions of granulocyte-macrophage colony-stimulating factor. Crit Rev Immunol 2005, 5:405-428.
92. + regulatory T cells. J Immunol 2007, 179:3638-3647.
93. Codarri L., Gyulveszi G., Tosevski V., et al. ROR[gamma]t drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation. Nat Immunol 2011, 12(6):560-567.
94. Annunziato F., Cosmi L., Santarlasci V., Maggi L., Liotta F., Mazzinghi B., et al. Phenotypic and functional features of human Th17 cells. J Exp Med 2007, 204:1849-1861.
95. + regulatory T cells in humans. Proc Natl Acad Sci USA 2009, 106:4793-4798.
96. Aggarwal S., Ghilardi N., Xie M.H., de Sauvage F.J., Gurney A.L. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J Biol Chem 2003, 278:1910-1914.
97. Parham C., Chirica M., Timans J., Vaisberg E., Travis M., Cheung J., et al. A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R. J Immunol 2002, 168:5699-5708.
98. Yang X.O., Nurieva R., Martinez G.J., Kang H.S., Chung Y., Pappu B.P., et al. Molecular antagonism and plasticity of regulatory and inflammatory T cell programs. Immunity 2008, 29:44-56.
99. Bending D., De la Peña H., Veldhoen M., Phillips J.M., Uyttenhove C., Stockinger B., et al. Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD/SCID recipient mice. J Clin Invest 2009, 119:565-572.
100. + T cells. J Exp Med 2008, 205:1381-1393.
101. Du J., Huang C., Zhou B., Ziegler S.F. Isoform-specific inhibition of ROR alpha-mediated transcriptional activation by human FOXP3. J Immunol 2008, 180:4785-4792.
102. + T cells or are self-induced to become Th17 cells in the absence of exogenous TGF-beta. J Immunol 2007, 178:6725-6729.
103. Osorio F., LeibundGut-Landmann S., Lochner M., Lahl K., Sparwasser T., Eberl G., et al. DC activated via dectin-1 convert Treg into IL-17 producers. Eur J Immunol 2008, 38:3274-3281.
104. Zhou X., Baily-Bucktrout S.L., Jeker L.T., Penaranda C., Martinez-Llordella M., Ashby M., et al. Instability of transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo. Nat Immunol 2009, 10:1000-1007.
105. + T cells in to Th17 cells in autoimmune arthritis. Nat Med 2014, 20(1):62-68.
106. Ansel K.M., Lee D.U., Rao A. An epigenetic view of helper T cell differentiation. Nat Immunol 2003, 4:616-623.
107. Wilson C.B., Rowell E., Sekimata M. Epigenetic control of T helper-cell differentiation. Nat Rev Immunol 2009, 9:91-105.
108. Roh T.Y., Cuddapah S., Cui K., Zhao K. The genomic landscape of histone modifications in human T cells. Proc Natl Acad Sci USA 2006, 103:15782-15787.
109. Schones D.E., Cui K., Cuddapah S., Roh T.Y., Barski A., Wang Z., et al. Dynamic regulation of nucleosome positioning in the human genome. Cell 2008, 132:887-898.
110. + T cells. Immunity 2009, 30:155-167.
111. Bernstein B.E., Mikkelsen T.S., Xie X., Kamal M., Huebert D.J., Cuff J., et al. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 2006, 125:315-326.
112. Kanagawa O., Xu G., Tevaarwerk A., Vaupel B.A. Protection of NOD mice from diabetes by gene(s) closely linked to IFN-g receptor loci. J Immunol 2000, 164(7):3919-3923.
113. Wang B., André I., Gonzalez A., Katz J.D., Aguet M., Benoist C., et al. IFN-gamma impacts at multiple points during the progression of autoimmune diabetes. Proc Natl Acad Sci USA 1997, 94(25):13844-13849.
114. Hultgren B., Huang X., Dybdal N., Stewart T.A. Genetic absence of IFN-g delays but does not prevent diabetes in NOD mice. Diabetes 1996, 45(6):812-817.
115. Serreze D.V., Post C.M., Chapman H.D., Johnson E.A., Lu B., Rothman P.B. Interferon-g receptor signalling is dispensable in the development of autoimmune type 1 diabetes in NOD mice. Diabetes 2000, 49(12):2007-2011.
116. Mensah-Brown E.P., Shahin A., Al-Shamisi M., Wei X., Lukic M.L. IL-23 leads to diabetes induction after subdiabetogenic treatment with multiple low doses of streptozotocin. Eur J Immunol 2006, 36:216-223.
117. Jain R., Tartar D.M., Gregg R.K., Divekar R.D., Bell J.J., Lee H.H., et al. Innocuous IFNgamma induced by adjuvant-free antigen restores normoglycemia in NOD mice through inhibition of IL-17 production. J Exp Med 2008, 205:207-218.
118. Zhang J., Huang Z., Sun R., Tian Z., Wei H. IFN-g induced by IL-12 administration prevents diabetes by inhibiting pathogenic IL-17 production in NOD mice. J Autoimmun 2012, 38:20-28.
119. Emamaullee J.A., Davis J., Merani S., Toso C., Elliott J.F., Thiesen A., et al. Inhibition of Th17 cells regulates autoimmune diabetes in NOD mice. Diabetes 2009, 58:1302-1311.
120. Wang M., Yang L., Sheng X., Chen W., Tang H., Sheng H., et al. T-cell vaccination leads to suppression of intrapancreatic Th17 cells through Stat3-mediated RORγt inhibition in autoimmune diabetes. Cell Res 2011, 21(9):1358-1369.
121. Spolski R., Kashyap M., Robinson C., Yu Z., Leonard W.J. IL-21 signaling is critical for the development of type I diabetes in the NOD mouse. Proc Natl Acad Sci USA 2008, 105:14028-14033.
122. Van Belle T.L., Nierkens S., Arens R., von Herrath M.G. Interleukin-21receptor-mediated signals control autoreactive T cell infiltration in pancreatic islets. Immunity 2012, 36:1060-1072.
123. Kuriya G., Uchida T., Akazawa S., Kobayashi M., Nakamura K., Satoh T., et al. Double deficiency in IL-17 and IFN-γ signalling significantly suppresses the development of diabetes in the NOD mouse. Diabetologia 2013, 56(8):1773-1780.
124. Wan X., Guloglu F.B., VanMorlan A.M., Rowland L.M., Jain R., Haymaker C.L., et al. Mechanisms underlying antigen-specific tolerance of stable and convertible Th17 cells during suppression of autoimmune diabetes. Diabetes 2012, 61:2054-2065.
125. Joseph J., Bittner S., Kaiser F.M., Wiendl H., Kissler S. IL-17 silencing does not protect nonobese diabetic mice from autoimmune diabetes. J Immunol 2012, 188:216-221.
126. Liu S.M., Lee D.H., Sullivan J.M., Chung D., Jäger A., Shum B.O., et al. Differential IL-21 signaling in APCs leads to disparate Th17 differentiation in diabetes-susceptible NOD and diabetes-resistant NOD.Idd3 mice. J Clin Invest 2011, 121:4303-4310.
127. Tse H.M., Thayer T.C., Steele C., Cuda C.M., Morel L., Piganelli J.D., et al. NADPH oxidase deficiency regulates Th lineage commitment and modulates autoimmunity. J Immunol 2010, 185(9):5247-5258.
128. + T cells in the pathogenesis of organ specific autoimmune diseases. Immunol Today 1995, 16:34-38.
129. Serreze D.V., Leiter E.H. Defective activation of T suppressor cell function in nonobese diabetic mice: potential relation to cytokine deficiencies. J Immunol 1988, 140:3801-3807.
130. + T cells selected by I-Ag7 on a nonobese diabetic versus C57BL/6 genetic background. J Immunol 2001, 167:1693-1702.
131. Li C.R., Muller E.E., Bradely L.M. Islet antigen-specific Th17 cells can induce TNF-a dependant autoimmune diabetes. J Immunol 2014, 192(4):1425-1432.
132. Lau K., Benitez P., Ardissone A., Wilson T.D., Collins E.L., et al. Inhibition of type 1 diabetes correlated to a Lactobacillus johnsonii N6.2-mediated Th17 bias. J Immunol 2011, 186:3538-3546.
133. Nikoopour E., Schwartz J.A., Huszarik K., Sandrock C., Krougly O., et al. Th17 polarized cells from nonobese diabetic mice following mycobacterial adjuvant immunotherapy delay type 1 diabetes. J Immunol 2010, 184:4779-4788.
134. Bradshaw E.M., Raddassi K., Elyaman W., Orban T., Gottlieb P.A., et al. Monocytes from patients with type 1 diabetes spontaneously secretes proinflammatory cytokines inducing Th17 cells. J Immunol 2009, 183:4432-4439.
135. Marwaha A.K., Crome S.Q., Panagiotopoulos C., Berg K.B., Qin H., Ouyang Q., et al. Cutting edge: increased IL-17-secreting T cells in children with new-onset type 1 diabetes. J Immunol 2010, 185:3814-3818.
136. Honkanen J., Nieminen J.K., Gao R., Luopajarvi K., Salo H.M., Ilonen J., et al. IL-17 immunity in human type 1 diabetes. J Immunol 2010, 185:1959-1967.
137. Arif S., Moore F., Marks K., Bouckenooghe T., Dayan C.M., Planas R., et al. Peripheral and islet interleukin-17 pathway activation characterizes human autoimmune diabetes and promotes cytokine-mediated β-cell death. Diabetes 2011, 60:2112-2119.
138. Ryba-Stanisławowska M., Skrzypkowska M., Myśliwiec M., Myśliwska J. Loss of the balance between CD4(+)Foxp3(+) regulatory T cells and CD4(+)IL17A(+) Th17 cells in patients with type 1 diabetes. Hum Immunol 2013, 74(6):701-707.
139. Ferraro A., Socci C., Stabilini A., Valle A., Monti P., Piemonti L., et al. Expansion of Th17 cells and functional defects in T regulatory cells are key features of the pancreatic lymph nodes in patients with type 1 diabetes. Diabetes 2011, 60(11):2903-2913.
140. Kumar P., Natarajan K., Shanmugam N. High glucose driven expression of pro-inflammatory cytokine and chemokine genes in lymphocytes: molecular mechanisms of IL-17 family gene expression. Cell Signal 2014, 26(3):528-539.
141. Sumarc-Domanovic M., Jeremic D., Pantovic A., Janjetovic K., Stamenkovic-Pejkovic D., Cvjovic G., et al. Therapeutic improvement of lucoregulation in newly diagnosed type 2 diabetes patients is associated with a reduction of IL-17 levels. Immunobiology 2013, 218(8):113-118.
142. Jagannathan-Bogdan M., McDonnell M.E., Shin H., Rehman Q., Hasturk H., Apovian C.M., et al. Elevated proinflammatory cytokine production by a skewed T cell compartment requires monocytes and promotes inflammation in type 2 diabetes. J Immunol 2011, 186(2):1162-1172.